Aaron M Teitelbaum

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 8

Top Topics

Capillary Electrophoresis

Top Venues

Journal of medicinal chemistry

Drug metabolism and disposition: the biological fate of chemicals

Drug metabolism reviews

The Journal of pharmacology and experimental therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Sven Thamm, Marina K Willwacher, Gary E Aspnes, Tom Bretschneider, Nicholas F Brown, Silke Buschbom-Helmke, Thomas Fox, Emanuele M Gargano, Daniel Grabowski, Christoph Hoenke, Damian Matera, Katja Mueck, Stefan Peters, Sophia Reindl, Doris Riether, Matthias Schmid, Christofer S Tautermann, Aaron M Teitelbaum, Cornelius Trünkle, Thomas Veser, Martin Winter, Lars Wortmann
Discovery of a Novel Potent and Selective HSD17B13 Inhibitor, BI-3231, a Well-Characterized Chemical Probe Available for Open Science. Journal of medicinal chemistry 66 (4) (2023)
Sven Thamm, Marina K Willwacher, Gary E Aspnes, Tom Bretschneider, Nicholas F Brown, Silke Buschbom-Helmke, Thomas Fox, Emanuele M Gargano, Daniel Grabowski, Christoph Hoenke, Damian Matera, Katja Mueck, Stefan Peters, Sophia Reindl, Doris Riether, Matthias Schmid, Christofer S Tautermann, Aaron M Teitelbaum, Cornelius Trünkle, Thomas Veser, Martin Winter, Lars Wortmann
Discovery of a Novel Potent and Selective HSD17B13 Inhibitor, BI-3231, a Well-Characterized Chemical Probe Available for Open Science. Journal of medicinal chemistry (2023)
Sven Thamm, Marina K Willwacher, Gary E Aspnes, Tom Bretschneider, Nicholas F Brown, Silke Buschbom-Helmke, Thomas Fox, Emanuele M Gargano, Daniel Grabowski, Christoph Hoenke, Damian Matera, Katja Mueck, Stefan Peters, Sophia Reindl, Doris Riether, Matthias Schmid, Christofer S Tautermann, Aaron M Teitelbaum, Cornelius Trünkle, Thomas Veser, Martin Winter, Lars Wortmann
Discovery of a Novel Potent and Selective HSD17B13 Inhibitor, BI-3231, a Well-Characterized Chemical Probe Available for Open Science. Journal of medicinal chemistry 66 (4) (2023)
Sven Thamm, Marina K Willwacher, Gary E Aspnes, Tom Bretschneider, Nicholas F Brown, Silke Buschbom-Helmke, Thomas Fox, Emanuele M Gargano, Daniel Grabowski, Christoph Hoenke, Damian Matera, Katja Mueck, Stefan Peters, Sophia Reindl, Doris Riether, Matthias Schmid, Christofer S Tautermann, Aaron M Teitelbaum, Cornelius Trünkle, Thomas Veser, Martin Winter, Lars Wortmann
Discovery of a Novel Potent and Selective HSD17B13 Inhibitor, BI-3231, a Well-Characterized Chemical Probe Available for Open Science. Journal of medicinal chemistry 66 (4) (2023)
Sven Thamm, Marina K Willwacher, Gary E Aspnes, Tom Bretschneider, Nicholas F Brown, Silke Buschbom-Helmke, Thomas Fox, Emanuele M Gargano, Daniel Grabowski, Christoph Hoenke, Damian Matera, Katja Mueck, Stefan Peters, Sophia Reindl, Doris Riether, Matthias Schmid, Christofer S Tautermann, Aaron M Teitelbaum, Cornelius Trünkle, Thomas Veser, Martin Winter, Lars Wortmann
Discovery of a Novel Potent and Selective HSD17B13 Inhibitor, BI-3231, a Well-Characterized Chemical Probe Available for Open Science. Journal of medicinal chemistry 66 (4) (2023)
S Cyrus Khojasteh, Upendra A Argikar, James P Driscoll, Carley J S Heck, Lloyd King, Klarissa D Jackson, Wenying Jian, Amit S Kalgutkar, Grover P Miller, Valerie M Kramlinger, Ivonne M C M Rietjens, Aaron M Teitelbaum, Kai Wang, Cong Wei
Novel advances in biotransformation and bioactivation research - 2020 year in review. Drug metabolism reviews 53 (3) (2021)
Valerie M Kramlinger, Deepak Dalvie, Carley J S Heck, Amit S Kalgutkar, James O'Neill, Dian Su, Aaron M Teitelbaum, Rheem A Totah
Future of Biotransformation Science in the Pharmaceutical Industry. Drug metabolism and disposition: the biological fate of chemicals 50 (3) (2021)
Aaron M Teitelbaum, Matthew G McDonald, John P Kowalski, Oliver T Parkinson, Michele Scian, Dale Whittington, Katharina Roellecke, Helmut Hanenberg, Constanze Wiek, Allan E Rettie
Influence of Stereochemistry on the Bioactivation and Glucuronidation of 4-Ipomeanol. The Journal of pharmacology and experimental therapeutics 368 (2) (2018)